Particle News: Latest Tirzepatide news

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

Scott Disick Addresses Weight Loss Drug Appearance on 'The Kardashians'

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

UK Reports 82 Deaths Potentially Linked to Popular Weight-Loss Drugs

Whoopi Goldberg Warns of Fake AI Ad Using Her Image for Weight Loss Drug

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

FDA Ends Shortage of Tirzepatide, Restricts Compounded Weight-Loss Drugs

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

GLP-1 Drugs Revolutionize Prescriptions and Broader Health Applications

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Rory McIlroy's On-Air Joke About Charles Barkley's Weight Draws Attention During Golf Exhibition

Weight-Loss Injections Linked to Increased Fertility and 'Ozempic Babies'

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

Bonnie Chapman Shares 60-Pound Weight Loss Journey Using Tirzepatide

Jim Gaffigan Discusses Weight Loss and New Comedy Special

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

UK Regulators Warn Against Misuse of Weight-Loss Injections

Cost Concerns Limit Medicaid Coverage of Weight-Loss Drugs

Eli Lilly Sues Vendors for Selling Unauthorized Tirzepatide Products

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Eli Lilly Introduces Affordable Zepbound Vials to Address Obesity Drug Shortage

Eli Lilly's Tirzepatide Shows 94% Reduction in Diabetes Risk

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Weight-Loss Drugs Reshape Health and Consumer Markets

Roche Accelerates Development of Promising Weight-Loss Pills

Eli Lilly's Mounjaro Outperforms Novo Nordisk's Ozempic in Weight Loss Study

Tori Spelling Flaunts New Look After Weight Loss Journey

Biden and Sanders Demand Lower Prices for Popular Weight-Loss Drugs

New Drug Tirzepatide Shows Promise in Treating Sleep Apnea and Obesity

Weight-Loss Drug Market Expands with New Generic Versions

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

WHO and Eli Lilly Warn of Dangerous Fake Weight-Loss Drugs

Michigan's Largest Insurer Ends Coverage for Costly Weight-Loss Drugs

UK Approves Mounjaro for Obesity Treatment, Offering Alternative to Wegovy

Lizzo Reacts to 'South Park' Episode Featuring Her as a Weight-Loss Alternative

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

Beyond Weight Loss: GLP-1 Drugs Show Promising Health Benefits

Terry Dubrow Calls for Transparency in Weight Loss Drug Discussions

Lauren Manzo Responds to Criticism Over Her 100-Pound Weight Loss

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Eli Lilly's Zepbound Shows Promise in Treating Sleep Apnea and Obesity

Tori Spelling Discusses Challenges and Personal Revelations After Five C-Sections

Oprah Winfrey and Whoopi Goldberg Share Personal Weight Loss Journeys, Advocating for Compassion

Lauren Manzo Addresses Weight Loss Criticism Amid Divorce Proceedings

Eli Lilly's Tirzepatide Shows Promising Results in MASH Treatment, Fuels Revenue Growth

Eli Lilly's Weight-Loss Drug Zepbound and Diabetes Treatment Mounjaro Drive Record Earnings

Tirzepatide Shows Promising Results in Lowering Blood Pressure Among Obese Adults

Eli Lilly Surpasses Tesla in Market Cap Amid EV Maker's Stock Plunge

Drugmakers Raise Prices for Over 700 Medications, Including Popular Weight-Loss Drugs Ozempic and Mounjaro

Boy George Reveals Tummy Tuck, Hair Transplants and Use of Weight Loss Drug Mounjaro in New Memoir

Eli Lilly Launches Telehealth Platform Amid Surge in Demand for Weight Loss Drugs

New Weight-Loss Drugs Transform Obesity Treatments Amid High Costs and Accessibility Challenges

WeightWatchers Launches Program for Weight Loss Drug Users

Continued Use of New Obesity Drug Tirzepatide Crucial for Maintaining Weight Loss

Mounjaro Outperforms Ozempic in Weight Loss, Study Finds

Mounjaro Outperforms Ozempic in Weight Loss, Real-World Study Shows

Weight-Loss Drugs Transform Thanksgiving Experience for Users

Pharma Giants Capitalize on Rising U.S. Obesity Rates with Weight-Loss Treatments

Eli Lilly to Invest $2.17 Billion in New German Plant

FDA Approves New Weight-Loss Drug Zepbound Amid Reports of Counterfeit Weight-Loss Medications

Weight-Loss Drug Market Expected to Reach $100 Billion by 2030; Listed Prices Misleadingly High Compared to Actual Payment Received by Manufacturers

Diabetes Drug Mounjaro Helps Overweight Adults Lose Significant Weight in New Study

Diabetes drug Mounjaro drives record sales and share price highs for Eli Lilly on potential as obesity treatment

Drugmakers sued over gastrointestinal side effects of diabetes meds used off-label for weight loss

Experimental Obesity Drugs Prove Highly Effective in Recent Trials

Andy Cohen Jokes About 'Real Housewives' Stars Allegedly Using Diabetes Drug Ozempic for Weight Loss

Charles Barkley Loses Over 60 Pounds Using Diabetes Drug